scholarly journals An update on the global use of risk assessment models and thromboprophylaxis in hospitalized patients with medical illnesses from the World Thrombosis Day steering committee: systematic review and meta‐analysis

2021 ◽  
Author(s):  
Gabor Forgo ◽  
Evy Micieli ◽  
Walter Ageno ◽  
Lana A. Castellucci ◽  
Gabriela Cesarman‐Maus ◽  
...  
Keyword(s):  
Systematic Review ◽  
Risk Assessment ◽  
Meta Analysis ◽  
Steering Committee ◽  
Hospitalized Patients ◽  
Risk Assessment Models ◽  
The World

A systematic review of mobility/immobility in thromboembolism risk assessment models for hospitalized patients

2017 ◽  
Vol 44 (1) ◽  
pp. 94-103 ◽  
Author(s):  
Fan Ye ◽  
Carolyn Stalvey ◽  
Matheen A. Khuddus ◽  
David E. Winchester ◽  
Hale Z. Toklu ◽  
...  
Keyword(s):  
Systematic Review ◽  
Risk Assessment ◽  
Hospitalized Patients ◽  
Risk Assessment Models

A global systematic review, meta-analysis and health risk assessment on the quantity of Malathion, Diazinon and Chlorpyrifos in Vegetables

Chemosphere ◽  
2021 ◽  
Vol 270 ◽  
pp. 129382
Author(s):  
Majid Kermani ◽  
Mohsen Dowlati ◽  
Mitra Gholami ◽  
Hamid Reza Sobhi ◽  
Ali Azari ◽  
...  
Keyword(s):  
Systematic Review ◽  
Risk Assessment ◽  
Health Risk ◽  
Health Risk Assessment ◽  
Meta Analysis

scholarly journals Clinical effectiveness of convalescent plasma in hospitalized patients with COVID-19: a systematic review and meta-analysis

2021 ◽  
Vol 15 ◽  
pp. 175346662110280
Author(s):  
Roberto Ariel Abeldaño Zuñiga ◽  
Ruth Ana María González-Villoria ◽  
María Vanesa Elizondo ◽  
Anel Yaneli Nicolás Osorio ◽  
David Gómez Martínez ◽  
...  
Keyword(s):  
Systematic Review ◽  
Clinical Trials ◽  
Clinical Improvement ◽  
Data Extraction ◽  
Meta Analysis ◽  
Clinical Effectiveness ◽  
Risk Of Bias ◽  
Hospitalized Patients ◽  
Low Risk ◽  
Controlled Clinical Trials

Aims: Given the variability of previously reported results, this systematic review aims to determine the clinical effectiveness of convalescent plasma employed in the treatment of hospitalized patients diagnosed with COVID-19. Methods: We conducted a systematic review of controlled clinical trials assessing treatment with convalescent plasma for hospitalized patients diagnosed with SARS-CoV-2 infection. The outcomes were mortality, clinical improvement, and ventilation requirement. Results: A total of 51 studies were retrieved from the databases. Five articles were finally included in the data extraction and qualitative and quantitative synthesis of results. The overall risk of bias in the reviewed articles was established at low-risk only in two trials. The meta-analysis suggests that there is no benefit of convalescent plasma compared with standard care or placebo in reducing the overall mortality and the ventilation requirement. However, there could be a benefit for the clinical improvement in patients treated with plasma. Conclusion: Current results led to assume that the convalescent plasma transfusion cannot reduce the mortality or ventilation requirement in hospitalized patients diagnosed with SARS-CoV-2 infection. More controlled clinical trials conducted with methodologies that ensure a low risk of bias are still needed. The reviews of this paper are available via the supplemental material section.

Rate of polymyxin resistance among Acinetobacter baumannii recovered from hospitalized patients: a systematic review and meta-analysis

2020 ◽  
Vol 39 (8) ◽  
pp. 1427-1438
Author(s):  
William Gustavo Lima ◽  
Júlio César Moreira Brito ◽  
Bárbara Gatti Cardoso ◽  
Valbert Nascimento Cardoso ◽  
Magna Cristina de Paiva ◽  
...  
Keyword(s):  
Systematic Review ◽  
Acinetobacter Baumannii ◽  
Meta Analysis ◽  
Hospitalized Patients
Sign in / Sign up

Export Citation Format

Share Document